U.S. regulators defend requiring more data on monkeypox drug

U.S. regulators defend requiring more data on monkeypox drug To win approval, SIGA Chief Scientific Officer Dennis Hruby estimates it will likely take a 500-patient, placebo-controlled clinical trial in the United States. https://ift.tt/tz7djYP

EU says Novavax COVID shot must carry heart side-effect warning

EU says Novavax COVID shot must carry heart side-effect warning "We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S. vaccine developer Novavax added. https://ift.tt/tz7djYP

India registers 19,893 new COVID-19 cases, 53 deaths, active cases decline to 1,36,478

India registers 19,893 new COVID-19 cases, 53 deaths, active cases decline to 1,36,478 20,419 patients have recovered in the last 24 hours. The weekly positivity rate in the country currently stands at 4.64 per cent and the daily positivity rate is reported to be 4.94 per cent. https://ift.tt/tz7djYP

Govt looks to give booster shot to 3rd dose coverage

Govt looks to give booster shot to 3rd dose coverage The Delhi government has intensified its drive to reach out to all beneficiaries to administer them the third dose. All people who are 18 years and above and have completed six months or 26 weeks from the date of administration of the second dose are eligible for this free dose. https://ift.tt/tz7djYP